Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 1 | 52 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
UCSF Molecular Diagnostics Laboratory UCSF Molecular Diagnostics Laboratory University of California, San Francisco United States | 4 | 52 |
|
PRPF8 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Invitae United States | 57 | 27 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
qGenEx Intellectual disability Quantitative Genomic Medicine Laboratories, SL Spain | 3 | 1969 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Retinitis Pigmentosa, autosomal dominant and X-linked Amplexa Genetics Amplexa Genetics A/S Denmark | 2 | 30 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
Focused Inherited Retinal Disorders Panel PreventionGenetics, part of Exact Sciences United States | 36 | 31 |
|
PreventionGenetics, part of Exact Sciences United States | 91 | 82 |
|
Autosomal Dominant Retinitis Pigmentosa (RP) Panel PreventionGenetics, part of Exact Sciences United States | 32 | 30 |
|
Baylor Genetics United States | 842 | 637 |
|
Retinitis Pigmentosa via the PRPF8 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
VECMD Retina and Genomics Institute VECMD Mexico | 9 | 8 |
|
Comprehensive Hematologic Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 2 | 215 |
|
Myeloid Malignancies Mutation and Copy Number Variation Panel by Next Generation Sequencing ARUP Laboratories, Molecular Oncology ARUP Laboratories United States | 6 | 65 |
|
Genomic Unity® Retinal Disorders Analysis Variantyx, Inc. United States | 1 | 394 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.